Cytokinetics Inc (CYTK) insider trading

Every open-market stock purchase and sale by Cytokinetics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Robert I Blum (CEO) and 4 others sold $13.5M in the last 90 days.
  • Last insider buy: Bvf Partners L P/il (10% owner), $572K, 6 years ago.
  • Congress: Gilbert Cisneros bought $1K to $15K, 3 weeks ago.

Last 12 months: insiders bought $0 (0 buys) and sold $52.1M (78 sales). Last close $62.86 on Oct 21, 2026.

Recent CYTK insider trades

DateInsiderTradeValue
Oct 20, 2026Fady Ibraham Malik (VP)Sold$224K
Oct 20, 2026Fady Ibraham Malik (VP)Bought (not open market)$27.3K
Oct 20, 2026Fady Ibraham Malik (VP)Bought (not open market)—
Oct 16, 2026John T Henderson (Director)Bought (not open market)$22.5K
Oct 16, 2026James M Daly (Director)Bought (not open market)$12.5K
Oct 16, 2026Edward M. Kaye MD (Director)Bought (not open market)$12.5K
Oct 16, 2026Robert Arthur Harrington (Director)Bought (not open market)$12.5K
Oct 16, 2026Wendell Wierenga (Director)Bought (not open market)$6.2K
Oct 16, 2026Nancy Wysenski (Director)Bought (not open market)$6.2K
Oct 12, 2026Robert I Blum (CEO)Sold$472K
Oct 12, 2026Robert I Blum (CEO)Bought (not open market)$79.5K
Oct 12, 2026Robert I Blum (CEO)Bought (not open market)—
Oct 6, 2026Fady Ibraham Malik (VP)Sold$215K
Oct 6, 2026Fady Ibraham Malik (VP)Bought (not open market)—
Sep 29, 2026Gilbert Cisneros (Representative)Bought$1K–15K
Sep 28, 2026Robert I Blum (CEO)Sold$491K
Sep 28, 2026Robert I Blum (CEO)Bought (not open market)—
Sep 22, 2026Fady Ibraham Malik (VP)Sold$239K
Sep 22, 2026Fady Ibraham Malik (VP)Bought (not open market)—
Sep 15, 2026Robert I Blum (CEO)Sold$6.8M
Sep 15, 2026Robert E Landry (Director)Sold$72.1K
Sep 14, 2026Robert I Blum (CEO)Sold$551K
Sep 14, 2026Robert I Blum (CEO)Sold (not open market)—
Sep 14, 2026Robert I Blum (CEO)Bought (not open market)—
Sep 14, 2026Robert I Blum (CEO)Bought (not open market)—

Who's trading CYTK

Get free alerts when an insider at Cytokinetics Inc files a new trade →